Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03193021 · ClinicalTrials.gov registry record · NA
AMBULATE: Cardiva Mid-Bore VVCS vs. Manual Compression for Multiple Femoral Venous Access Sites, 6 - 12F ID
A NA study, sponsored by Cardiva Medical.
- Completed
- Registry status
- NA
- Development phase
- 204
- Enrollment target
NCT03193021 is a NA study that has completed, run by Cardiva Medical. The registered enrollment target is 204 participants.
The verdict
NCT03193021, a NA study, has completed, sponsored by Cardiva Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 204 participants
- Enrollment target
Study Summary
The objective of the trial is to demonstrate the safety and effectiveness of the Cardiva Mid-Bore Venous Vascular Closure System (VVCS) in sealing femoral venous access sites and providing reduced times to ambulation (TTA) compared with manual compression at the completion of catheter-based procedures performed through 6 - 12 Fr introducer sheaths.
Interventions
- OTHER Manual compression
- DEVICE Cardiva Mid-Bore VVCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2017-09-20 |
| Est. Completion | 2018-04-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03193021
The ClinicalTrials.gov registry entry for NCT03193021 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cardiva Medical, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Manual compression is the first listed.
NCT03193021 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03193021 about?
NCT03193021 is a clinical study titled "AMBULATE: Cardiva Mid-Bore VVCS vs. Manual Compression for Multiple Femoral Venous Access Sites, 6 - 12F ID". The objective of the trial is to demonstrate the safety and effectiveness of the Cardiva Mid-Bore Venous Vascular Closure System (VVCS) in sealing femoral venous access sites and providing reduced times to ambulation (TTA) compared with manual compression at the completion of catheter-based procedur...
What is the current status of trial NCT03193021?
This trial is currently completed. It is a NA study. The enrollment target is 204 participants. The study started on 2017-09-20. Estimated completion is 2018-04-13.
What interventions are being tested in trial NCT03193021?
The interventions under investigation include: Manual compression (OTHER), Cardiva Mid-Bore VVCS (DEVICE).
Who is sponsoring clinical trial NCT03193021?
This trial is sponsored by Cardiva Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.